GLP-1 Agonists: A Comprehensive Overview
US$ 26.42
health benefits of glp-1 agonists The cardiovascular effects receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 Agonists in Cardiovascular Diseases:
Description
drug repurposing
p38beta Mitogen- activated protein kinase signaling mediates exenatide-stimulated microglial beta-endorphin expression
For candidates on GLP-1s, a few specific factors come into focus
Our mission is simple: empower every person to make informed health decisions through content that is accurate, accessible, and free from misinformation
In addition, recent trends in the burden of vascular risk factors in young adult ischemic stroke patients have attracted attention (Shoskes et al., 2025)
